Trending News

More News >

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Popular

AI Analyst Top Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

Neuren Pharmaceuticals Limited (NURPF)

OTHER OTC:NURPF

NURPF

Neuren Pharmaceuticals Limited

RESEARCH TOOLSreports

Neuren Pharmaceuticals Limited (NURPF) Ratios

Compare

56 Followers

Neuren Pharmaceuticals Limited Ratios

NURPF's free cash flow for Q4 2025 was AU$1.00. For the 2025 fiscal year, NURPF's free cash flow was decreased by AU$ and operating cash flow was AU$0.31. See a summary of the company’s cash flow.

Ratios	TTM	Dec 25	Dec 24	Dec 23	Dec 22
Liquidity Ratios
Current Ratio	76.60	76.60	8.73	5.78	25.77
Quick Ratio	76.60	76.60	8.73	5.78	25.77
Cash Ratio	0.97	0.97	0.07	0.40	23.95
Solvency Ratio	6.91	6.91	3.10	3.67	0.12
Operating Cash Flow Ratio	28.92	28.92	-0.25	4.32	2.14
Short-Term Operating Cash Flow Coverage	0.00	0.00	0.00	0.00	0.00
Net Current Asset Value	AU$ 327.83M	AU$ 327.83M	AU$ 353.52M	AU$ 204.39M	AU$ 41.57M
Leverage Ratios
Debt-to-Assets Ratio	0.00	0.00	0.00	0.00	0.00
Debt-to-Equity Ratio	0.00	0.00	0.00	0.00	0.00
Debt-to-Capital Ratio	0.00	0.00	0.00	0.00	0.00
Long-Term Debt-to-Capital Ratio	0.00	0.00	0.00	0.00	0.00
Financial Leverage Ratio	1.01	1.01	1.13	1.21	1.04
Debt Service Coverage Ratio	0.00	0.00	0.00	0.00	0.00
Interest Coverage Ratio	0.00	0.00	0.00	0.00	0.00
Debt to Market Cap	0.00	0.00	0.00	0.00	0.00
Interest Debt Per Share	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	-0.19	-0.19	-0.02	-0.09	59.97
Profitability Margins
Gross Profit Margin	76.93%	99.96%	99.99%	88.47%	99.93%
EBIT Margin	34.07%	34.07%	82.32%	85.89%	-4.67%
EBITDA Margin	34.11%	34.11%	82.33%	85.92%	-4.60%
Operating Profit Margin	11.03%	34.07%	82.32%	74.37%	-10.97%
Pretax Profit Margin	60.23%	60.23%	85.79%	88.45%	-4.67%
Net Profit Margin	47.09%	47.09%	66.61%	67.73%	1.26%
Continuous Operations Profit Margin	47.09%	47.09%	66.61%	67.73%	1.26%
Net Income Per EBT	78.18%	78.18%	77.64%	76.57%	-27.06%
EBT Per EBIT	546.22%	176.76%	104.21%	118.93%	42.61%
Return on Assets (ROA)	8.88%	8.88%	34.67%	63.35%	0.43%
Return on Equity (ROE)	9.20%	8.99%	39.03%	76.55%	0.44%
Return on Capital Employed (ROCE)	2.11%	6.51%	48.24%	84.06%	-3.84%
Return on Invested Capital (ROIC)	1.65%	5.09%	37.45%	64.37%	1.04%
Return on Tangible Assets	8.88%	8.88%	34.67%	63.35%	0.43%
Earnings Yield	2.10%	1.28%	8.89%	4.98%	0.02%
Efficiency Ratios
Receivables Turnover	2.44	2.44	1.23	16.09	13.36
Payables Turnover	6.21	0.03	0.02	39.63	0.04
Inventory Turnover	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	1.44K	1.44K	6.88K	5.39K	693.00
Asset Turnover	0.19	0.19	0.52	0.94	0.34
Working Capital Turnover Ratio	0.20	0.19	0.76	1.89	0.36
Cash Conversion Cycle	91.09	-13.77K	-23.74K	13.47	-9.39K
Days of Sales Outstanding	149.89	149.89	295.96	22.68	27.31
Days of Inventory Outstanding	0.00	0.00	0.00	0.00	0.00
Days of Payables Outstanding	58.81	13.92K	24.04K	9.21	9.42K
Operating Cycle	149.89	149.89	295.96	22.68	27.31
Cash Flow Ratios
Operating Cash Flow Per Share	0.99	0.98	-0.09	1.46	0.03
Free Cash Flow Per Share	0.99	0.98	-0.09	1.45	0.03
CapEx Per Share	<0.01	<0.01	<0.01	<0.01	<0.01
Free Cash Flow to Operating Cash Flow	1.00	1.00	1.00	1.00	0.99
Dividend Paid and CapEx Coverage Ratio	3.39K	3.39K	-1.13K	4.62K	189.42
Capital Expenditure Coverage Ratio	3.39K	3.39K	-1.13K	4.62K	189.42
Operating Cash Flow Coverage Ratio	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Sales Ratio	1.94	1.94	-0.05	0.80	0.25
Free Cash Flow Yield	8.63%	5.25%	-0.71%	5.86%	0.36%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	47.72	78.41	11.24	20.08	5.44K
Price-to-Sales (P/S) Ratio	22.47	36.92	7.49	13.60	68.81
Price-to-Book (P/B) Ratio	4.29	7.05	4.39	15.37	24.08
Price-to-Free Cash Flow (P/FCF) Ratio	11.58	19.03	-141.59	17.06	279.73
Price-to-Operating Cash Flow Ratio	11.58	19.03	-141.71	17.05	278.25
Price-to-Earnings Growth (PEG) Ratio	-0.60	-1.00	-1.07	<0.01	-53.22
Price-to-Fair Value	4.29	7.05	4.39	15.37	24.08
Enterprise Value Multiple	65.69	108.06	9.08	15.74	-1.43K
Enterprise Value	1.45B	2.38B	1.59B	3.14B	961.25M
EV to EBITDA	65.69	108.06	9.08	15.74	-1.43K
EV to Sales	22.41	36.86	7.47	13.52	66.05
EV to Free Cash Flow	11.55	19.00	-141.31	16.97	268.50
EV to Operating Cash Flow	11.55	18.99	-141.43	16.96	267.09
Tangible Book Value Per Share	2.67	2.64	2.85	1.61	0.33
Shareholders’ Equity Per Share	2.67	2.64	2.85	1.61	0.33
Tax and Other Ratios
Effective Tax Rate	0.22	0.22	0.22	0.23	1.27
Revenue Per Share	0.51	0.50	1.67	1.83	0.12
Net Income Per Share	0.24	0.24	1.11	1.24	<0.01
Tax Burden	0.78	0.78	0.78	0.77	-0.27
Interest Burden	1.77	1.77	1.04	1.03	1.00
Research & Development to Revenue	0.56	0.56	0.15	0.12	0.87
SG&A to Revenue	0.04	0.00	0.02	0.03	0.24
Stock-Based Compensation to Revenue	<0.01	0.00	0.00	0.00	0.14
Income Quality	4.12	4.12	-0.08	1.18	19.56

Currency in AUD